Chimeric antigen receptor T‐cell therapy: Challenges and framework of outpatient administration
Clicks: 69
ID: 278430
2022
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
2.4
/100
8 views
8 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Abstract Adoptive cellular therapy has made a landmark change within the treatment paradigm of several hematologic malignancies, and novel cellular therapy products, such as chimeric antigen receptor T‐cell therapy (CART), have demonstrated impressive efficacy and produced durable responses. However, the CART treatment process is associated with significant toxicities, healthcare resource utilization, and financial burden. Most of these therapies have been administered in the inpatient setting due to their toxicity profile. Improved toxicity management strategies and a better understanding of cellular therapy processes are now established. Therefore, efforts to transition CART to the outpatient setting are warranted with the potential to translate into enhanced patient quality of life and cost savings. A successful launch of outpatient CART requires several components including a multidisciplinary cellular therapy team and an outpatient center with appropriate clinical space and personnel. Telemedicine should be incorporated for closer monitoring. Additionally, clear criteria for admission upon clinical decompensation, a pathway for prompt inpatient transition, and clear toxicity management guidelines should be implemented. Effective education about cellular therapy and toxicity management is imperative, especially for the Emergency Department and Intensive Care Unit teams. Here, we have outlined the various logistical and clinical considerations required for the care of CART patients, which will aid centers to establish an outpatient CART program.
| Reference Key |
gatwood2022chimericejhaem
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Gatwood, Katie S.;Dholaria, Bhagirathbhai R.;Lucena, Mariana;Baer, Brittney;Savani, Bipin N.;Oluwole, Olalekan O.; |
| Journal | eJHaem |
| Year | 2022 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
chemistry
Ecology
microscopy
Biology (General)
Medicine
Engineering (General). Civil engineering (General)
Technology
Electrical engineering. Electronics. Nuclear engineering
Descriptive and experimental mechanics
Science
Diseases of the blood and blood-forming organs
physics
neurology. diseases of the nervous system
neoplasms. tumors. oncology. including cancer and carcinogens
electronics
diseases of the genitourinary system. urology
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.